Coagulation and RFLP data from 41 families with an isolated haemophilia A patient were used to estimate the sex ratio of mutation frequencies (v/>). Based on the results of coagulation assays in all the female relatives investigated, v/" was estimated to be 12-1 by the maximum likelihood method (95% confidence interval 3-8 to 62-5). In order to avoid the possible influence of germline mosaicism, an additional analysis was performed in which only the results in the mothers and grandmothers of an isolated patient were included. The v/" ratio was then estimated to be 5 2 (95% confidence interval 1-8 to 15-1).
One-third of patients with haemophilia have no affected male relatives.) Therefore, the question of which of the female relatives of these isolated patients are at risk for being a carrier is of major importance in genetic counselling for haemophilia.
The probability of carriership for female relatives of isolated patients is determined by the origin of the mutation in the family and depends on the ratio of the mutation frequency in males (v) and females (p). If mutations occur predominantly in males, a high proportion of the mothers of an isolated patient will be carriers of the disease. On the other hand, the more often mutations occur in females, the more isolated patients will be sons of non-carrier mothers and be so-called 'true sporadic patients'.
The sex ratio of the mutation frequencies (v/ji) for haemophilia has been estimated by different methods. In 1935, Haldane3 showed that for X linked recessive diseases v/ji can be derived from the proportion of sporadic patients of all patients (x) by the equation x = p/(2p + v), provided that genetic equilibrium is present. This proportion x is expected to be 1/3, when v/j equals 1. The proportion of sporadic cases is expected to be lower than 1/3 when mutations occur more frequently in males than in females, and also when affected males have significant reproductive fitness. Theoretically, the fitness of carrier females may be of influence as well. A modi-In addition to genetic equilibrium, Haldane's method requires complete or unbiased ascertainment of affected males or mothers of an affected male. If ascertainment is incomplete, families with more than one affected male are more likely to be included, which leads to an underestimation of the proportion of sporadic patients and, consequently, to an overestimation of v/j. In order to eliminate ascertainment bias, Davie and Emery5 and, later, Winter6 developed a method by which the proportion of sporadic patients (x) is estimated using only data from families with an isolated patient.
In haemophilia, genetic equilibrium is highly unlikely. Life expectancy of patients with haemophilia has markedly increased over the years,78 and so has their reproductive fitness.9 Therefore, the fitness of the patients who have contributed to the population under study is difficult to assess, and the assumption of a steady state is unwarranted.
Recently, we have argued that, under certain conditions, limitation of pedigree analysis to families with an (initially) isolated haemophilia patient allows an estimate of v/j independent of the fitness of affected males and of the existence of genetic equilibrium. 10 During requires so many pedigrees of a specific, infrequently occurring type that it is only feasible through large scale collaboration over a long period.
We have obtained an estimate of v/g from the results of coagulation assays and RFLP analysis in 41 families with an isolated haemophilia A patient. For the interpretation of the coagulation assays, we have developed a method that resembles the method described by Winter.6 From the RFLP data, information on the grandparental origin of the patient's X chromosome was used to estimate v/j. For this purpose the model of Muller and Grimm" was modified for application in families with an isolated haemophilia A patient.
Subjects and methods

SUBJECTS
We investigated subjects from 41 families with an isolated haemophilia A patient. All the families were referred to our centre during the years 1984 to 1989 for genetic counselling of the female relatives.
Extensive family histories, which covered information about the great grandfathers, grandfathers, brothers, cousins, nephews, uncles, and great uncles of the patient, were taken to exclude previously affected males in the pedigree. Since the occurrence of mild haemophilia cannot be reliably assessed in this way, we restricted the analysis to families in which the patient had a moderately severe (n= 6) or a severe (n = 35) form of haemophilia A, that is, less than 5% clotting factor VIII activity.
COAGULATION ASSAYS
Coagulation assays were performed in all the mothers of the isolated patients, in 19 of the 41 maternal grandmothers, and in 66 other female relatives, which included sisters, aunts, cousins, and nieces.
For this purpose, 9 ml of blood was obtained and added to 1 ml of sodium citrate (3 2% approach to obtain the confidence interval for v/j.
The log likelihood curves for v/g were constructed by maximisation of the original log likelihood with respect to 6, (at a fixed value of v/g).
In this study, it was impossible to estimate 6, with a high degree of precision. This is owing to lack of substantial information, that is, carrier detection tests, in the more remote generations. We found, however, that the log likelihood curve for v/" was not notably influenced by entering different values for 6,.
Estimation of the sex ratio of mutation frequencies by RFLP analysis From the results of RFLP analysis, the grandparental derivation of the X chromosome of an affected male can be deduced, irrespective of the generation in which the mutation occurred. We have evaluated the significance of the grandparental derivation of an isolated patient's X chromosome for the sex ratio of mutation frequencies (v/p).
The grandpaternal X chromosome (GP-X) may appear in an affected grandson because of a mutation during spermatogenesis resulting in a carrier daughter, who subsequently transmitted this X chromosome to her son (v/2) or because of a mutation in the patient's mother (f). The grandmaternal X chromosome (GM-X) may appear in an affected grandson because of carriership of the maternal grandmother (1/4Q), by a new mutation in the grandmother resulting in a carrier daughter who subsequently transmitted the X chromosome to her son (p/2), or because of a mutation in the patient's mother (ji). If we consider only families with no affected male relatives in the grandparental or more distant generations, the prior probability of carriership for the grandmother (Q) approximates 2p + 2v.'°The conditional probability for the patient's X chromosome having been inherited either from the grandfather or the grandmother is then GP-X: v/2 + p GM-X: (24 + 2v)/4 + p/2 + p and the ratio for the grandparental derivation
wherein v/ji is denoted by k. It can be seen that for this type of family, the ratio GP-X/GM-X is never expected to exceed 1, even if mutations occurred exclusively in males.
We restricted our investigation to families with an isolated patient which means that we excluded those in which the grandmothers had more than one descendant with haemophilia. The prior probability of carriership for the grandmothers in our study population is thus a fraction (t) of the prior probability for all the grandmothers with no previous family history of haemophilia. Accordingly, the ratio GP-X/GM-X in families with an isolated patient equals GP-X/GM-X = (k + 2)/t(k + 1) + 3 and depends not only on v/j, but also on the fraction of carrier grandmothers included in the analysis. If none of the carrier grandmothers is included (t = 0), the ratio GP-X/GM-X is expected to equal 1 in case g = v and to exceed 1 in case v > t. The more carrier grandmothers included (t> 0), the less likely that a higher mutation frequency in males will result in predominant inheritance of the grandpaternal X chromosome (fig 1) . In other words, whatever the value of t, when the patient's X chromosome is found to be derived more often from the grandfather than from the grandmother, this finding always indicates a higher mutation frequency in males. A minimum value of v/j can be derived from the ratio GP-X/GM-X, assuming t = 0. to be 12-1 with a 95% confidence interval of 3-8 to 62-5 ( fig 2) .
Results
ESTIMATION OF THE SEX RATIO OF MUTATION FREQUENCIES BY PEDIGREE ANALYSIS AND
In four of the families the patient's mother was more likely to be a carrier than a non-carrier, not on the basis of her own factor VIII levels but on the basis of those of her daughter. In these cases the daughters conferred on their mother an LR which almost equalled that of a second son with haemophilia (table 1) . Although normal factor VIII values may have been found in the mother because of preferential lyonisation of the mutated X chromosome, germline mosaicism may be an explanation as well.
In order to avoid the possible influence of this phenomenon, we performed an additional analysis, in which only the results of coagulation assays in mothers and grandmothers of the isolated patients were included. The ratio v/>t was then estimated to be 5-2 with a 95% confidence interval of 1 8 to 15.1 (fig 3) .
ESTIMATION OF THE SEX RATIO OF MUTATION FREQUENCIES BY RFLP ANALYSIS
From the results of RFLP analysis the grandparental derivation of the patient's X chromosome could be deduced in 22 of the 41 families (table 2) . The X chromosome of the patient was found to be derived from the grandfather twice as often as from the grandmother (GP-X/GM-X = 2). From fig 1 it follows that this finding corresponds with a minimum value for v/js of 4.
COMBINED RESULTS OF RFLP ANALYSIS AND COAGULATION ASSAYS
The most probable level of mutation for the grandpaternally and grandmaternally derived X chromosomes is depicted in fig 4 and is based on the results of coagulation assays in the mother and grandmother of the patient. Fourteen of the 15 mothers in whom the at risk X chromosome was of paternal origin had an LR-VIII above 1, 13 even above 10, so that in these cases the mutation most probably occurred in the grandfather of the patient. However, five of the seven mothers in whom the at risk X chromosome was of maternal origin had an LR-VIII below 1, so that in these cases the mutation most probably occurred in the mother of the patient. In the remaining two cases the mother as well as the grandmother of the patient had an LR-VIII above 1, which indicates that the mutation had occurred in the great grandparental or an even more remote generation.
Fourteen of the 22 mothers included in this figure are thus most probably carriers (LR-VIII > 1) by new mutation. It is striking that, in all these women, the mutation originated in the paternal X chromosome.
PROBABILITY OF CARRIERSHIP FOR MOTHERS OF AN ISOLATED PATIENT
The theoretical probability of carriership for mothers of an isolated patient was calculated to be 93% for a mutation ratio of 121 and 86% for a mutation ratio of 5-2. In addition to carriers in the classical sense, the first percentage may include women who are mosaic for the mutation, whereas the second percentage does not. In both analyses the remaining percentages of mothers, 7% and 14% The method which we have developed according to the model of Winter6 allows, in principle, inclusion of all types of pedigrees, irrespective of the number of affected males and of the generation(s) in which they occur. By basing the likelihood for the outcome of carrier detection tests on the pedigree information, that is, the number and genetic status of the male relatives, selection for a specific type of pedigree does not affect the estimated value of the parameters. At present, in view of the possible occurrence of mosaicism for mutations, we consider it advisable to limit this type of analysis to pedigrees with an isolated patient. Alternatively, when a certain value for v/j has been assumed, the method can be used for individual probability calculations in genetic counselling.
In this study, the estimate of v/j. appeared to be virtually independent of the prior probability of carriership for the woman in the pedigree designated the progenitor. In most of our pedigrees it concemed the great grandmother of the patient. The probability of carriership for the progenitor is determined by the mutation frequency in males and females as well as by the reproductive fitness in affected males. When more generations occur between patient and progenitor, the impact of Q1 on the carrier status of the mother of an isolated patient and, hence, the sex ratio of mutation frequencies, becomes less. As a consequence, the reproductive fitness of affected males, whatever the value, cannot be of major influence either.
When families with an isolated patient are ascertained through female relatives of the patient, the estimate of v/j. may be flawed by the referral pattem of these women. Since we are one of the major centres for carrier detection of haemophilia in the Netherlands, we cannot exclude the possibility that relatively more complex cases, that is, women who are difficult to classify, have been referred to us. In that case our estimate of v/f would be too low.
We have estimated v/j based exclusively on the results of coagulation assays in mothers and grandmothers of an isolated patient to avoid the possible influence of germline mosaicism. There appeared to be a considerable difference in the estimate based on coagulation assays in all available female relatives, 12-1 versus 5-2. The actual finding of germline mosaicism in one of the families included in this study25 has proven that the estimate of 12 1 may indeed be too high because of this phenomenon. The impact of germline mosaicism in haemophilia is, as yet, unknown. Therefore, a more conservative approach to estimate v/ft may be warranted.
To date, information from DNA studies on the origin of mutations is limited. Based on the results of RFLP analysis and of coagulation assays in families with an isolated patient, Bemardi et al37 arrived at a higher mutation frequency in males. It should be noted, however, that the chance to define the origin of the mutation by RFLP analysis depends on the information provided by the family and is easily biased in favour of males. We have chosen an approach by which limited, though unbiased, information from the RFLP studies, namely the grandparental derivation of the patient's X chromosome, was used to estimate v/j. For that purpose, we have defined the relationship between v/j and the ratio of grandpaternally and grandmaternally derived X chromosomes specifically for families with an isolated patient. A minimum estimate of v/tt could thus be obtained. In addition, we have shown that predominant inheritance of the grandmaternal X chromosome does not exclude a higher mutation frequency in males.
When the actual gene defect is known, the origin of the mutation can be unequivocally shown. In 22 haemophilia A families, the origin of the mutation has been reported. Knowledge of the sex ratio of mutation frequencies is important for genetic counselling in families with an isolated haemophilia A patient. The higher the v/", the higher is the probability of carriership for mothers of an isolated patient. The most conservative estimate of v/li in the present study (5 2) results in a probability of carriership of 86%. Although this implies that 14% of the mothers are not expected to be carriers in the classical sense, these mothers are not exempted from transmission of the same mutation to other children because of the possibility of germline mosaicism. As The probability for the genetic status of the subjects belonging to a specific pedigree is then the product of the individual probabilities n P(D1 .. ., Dn) = P(D1) H (DiJDmi) = 2D lF3H(J)C where F is the number of new female mutants, H is the number of new male mutants, and C is the number of children of carrier mothers. It should be noted that this expression includes pedigrees in which no mutation occurred (D1 + F + H = 0) as well as pedigrees in which a mutation occurred more than once (D1+ F + H > 1).
If we restrict the possible type of pedigrees to pedigrees with only one mutational event (DI + F + H = 1), the probability for the subjects of a specific pedigree becomes P(D,, ... ., n) = (D101 + F02 + H03)(I)C.
Since the selection of the investigated pedigrees from this population of pedigrees is unclear and depends on the genetic status of the males, we have used the probability of carriership for the females conditional on the genetic status of the males. Accordingly, the probability for the genetic status of the females in a specific pedigree is 
